MedTrace Logo

Quality of Life After Surgery for Pancreatic Carcinoma

NCT02175992 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-05-18

No results posted yet for this study

Summary

Pancreatic cancer has a high mortality rate. Patients with an intended curative resection show a median survival of 17-23 months. Therefore, quality of life is very important in this patient group. In this study, the effect of pancreatic surgery on quality of life is measured.

Conditions

  • Patients Suspected for a Pancreatic (Pre-)Malignancy

Sponsors & Collaborators

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Quintus Molenaar, MD PhD · UMC Utrecht

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2016-12-31
Completion
2017-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02175992 on ClinicalTrials.gov